Cryptobiotix

Cryptobiotix

Foundation date

27/01/2021

Sector

#Biotechnology - other

Subsector

• #Therapeutics - Peptides
• #Therapeutics - Proteins
• #Therapeutics - Small molecules
• #Therapeutics - Vaccines
• #Other - Food
• #Other - Industrial Biotechnology
• #Other - Nutraceuticals
• #Pharma - Anti-infectives
• #Pharma - Gene therapy
• #Pharma - Generics
• #Pharma - Nucleic acid drugs
• #Pharma - Small molecule therapeutics
• #Pharma - Vaccines

Therapeutic areas

• #Cardiovascular
• #Conditions originating in the perinatal period
• #Digestive system
• #Neoplasms / cancer / oncology
• #Respiratory system
• #Skin and subcutaneous tissue

Preclinical CRO in the gastrointestinal space offering in vitro digestion and ex vivo gut microbiome research services. Cryptobiotix pushes the boundaries of preclinical gastrointestinal research with unparalleled throughput and biorelevance. From early R&D screening to in-depth characterisation of food products and therapeutics, we tailor your project to your research questions and provide you the data to accelerate and de-risk your product development.